PTLF OTC
Petlife Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: -50.0%
YTD: +0.0%
1Y: +0.0%
3Y: -95.0%
5Y: -32.2%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$319K
-110.0% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$319K
-110.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$53K
+4429.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | -$2M | -$2M | -$4M | -$23M |
| Depreciation & Amort. | $72K | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $306K | $1M | $2M | $736K | $21M |
| Change in Working Capital | $334K | $0 | $361K | $3M | $453K |
| Other Non-Cash Items | $773K | $0 | $2M | $5K | $1M |
| Operating Cash Flow | -$137K | -$267K | -$22K | -$152K | -$319K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | -$600 | $0 | $0 |
| Acquisitions (Net) | $0 | $100K | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $100K | -$600 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $100K | $0 | $10K | $153K | $372K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $7K | -$11K | $6K | $0 | $0 |
| Financing Cash Flow | $137K | $174K | $16K | $153K | $372K |
| Net Change in Cash | -$67 | $7K | -$7K | $1K | $53K |
| Cash End of Period | $0 | $7K | $0 | $1K | $54K |
| Free Cash Flow | -$137K | -$267K | -$23K | -$152K | -$319K |